DNA Script's Series A Round

DNA Script raised a round of funding on September 12, 2017.

DNA Script manufactures de novo synthetic nucleic acids using an enzymatic technology. The company aims to introduce a novel biochemical process for DNA and RNA synthesis based on the use of efficient…

Articles about DNA Script's Series A Round: